MedTrace Logo

Ceftriaxone and Jaundice in Neonates

NCT03133637 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 27

Last updated 2021-04-06

No results posted yet for this study

Summary

Ceftriaxone is an antibiotic often used for the management of sepsis. Neonates commonly have jaundice during the first postnatal week. Ceftriaxone will be given as standard of care for sepsis and investigators will observe the effect on jaundice.

Conditions

  • Jaundice and Sepsis in Neonates

Interventions

DRUG

ceftriaxone

Eligible infants will receive ceftriaxone as standard of care for sepsis

Sponsors & Collaborators

  • University of Rochester

    lead OTHER

Eligibility

Min Age
3 Days
Max Age
7 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2019-08-31
Completion
2019-08-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03133637 on ClinicalTrials.gov